Please Wait.....
Report
South & Central America Genotyping Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product and Services (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology [Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others], Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others)
Market Report I 2022-09-16 I 152 Pages I The Insight Partners
The genotyping market in South & Central America is expected to grow from US$ 772.17 million in 2022 to US$ 1,889.89 million by 2028. It is estimated to grow at a CAGR of 16.1% from 2022 to 2028.
According to the study, personalized medicine is the customization of medical treatment to each patient's unique traits. The method is based on scientific advances in understanding how a person's unique molecular and genetic profile influences susceptibility to diseases and predicts which medical treatments are safe and effective and which are not. Senior government officials, corporate leaders, healthcare practitioners, and the general public have embraced genomics and personalized medicine over the last decade. Genomic medicine is a fundamental component of personalized medicine, a fast-growing health care branch guided by each person's unique clinical, genetic, genomic, and environmental information.
The fundamentals of genomic and personalized medicine will require the development, standardization, and integration of several essential tools into health systems and clinical workflows as medicine embraces genomic tools that enable more precise disease prediction and treatment, such as "whole-genome" interrogation of sequence variation, transcription, proteins, and metabolites. Among the techniques available are health risk assessment, family health history, and clinical decision assistance for complex risk and predictive information.
When combined with genomic data, these tools will enable a paradigm change toward a holistic strategy that will detect individual risks and guide clinical treatment and decision-making, laying the groundwork for a more informed and effective patient care approach. Genome-guided therapy, dose selection, DNA-based risk assessment for common complex diseases, and molecular signatures for cancer diagnosis and prognosis are examples of how genome information has already enabled personalized healthcare. For instance, genome-guided treatment is perhaps the most well-studied effect of precision medicine on health care today.
Clinicians have used genotype data as a guideline to calculate the correct warfarin dose. To assist doctors in optimizing pharmacological therapy based on genetic test results, the Clinical Pharmacogenetics Implementation Consortium produced genotype-based drug guidelines. For individuals with breast or lung cancer, genomic analysis of tumors can help guide tailored therapeutic approaches. When precision medicine is integrated into healthcare, it can provide more accurate diagnoses, anticipate disease risk before symptoms appear, and provide individualized treatment plans that maximize safety and efficiency.
Furthermore, data from individual genomes, a rapidly developing technology area, is causing a social and information revolution among customers, undoubtedly influencing healthcare decision-making. Although these and other scientific discoveries are making their way from the lab to the clinic, widespread acceptance of genomic and personalized medicine will necessitate significant changes in regulatory and reimbursement procedures and legislative privacy laws. Thus, customized healthcare challenges will be met and overcome with the assurance that the research behind genetic medicine is decent and that the practice of medicine that it informs is evidence-based. Over time, there has been a steady trend away from the old 'one pill fits all' strategy and toward a more individualized, patient-centered approach. Patients, health, and diseases are now treated with a more predictive, preventive, participatory, and individualized approach in medicine. This so-called P4 medicine has numerous problems and roadblocks, but it also presents numerous opportunities for improving care and therapeutic outcomes; therefore, such developments will represent a demand for personalized medicine, offering a growth curve for the market over the study period.
South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Genotyping Market Segmentation
The South & Central America genotyping market is segmented by products and services, technology, application, end user, and country. Based on products and services, the market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment is dominating the market in 2022.
Based on technology, the market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction (PCR), and others. The PCR segment is dominating the market in 2022.
Based on application, the market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. The diagnostics and personalized medicine segment is dominating the market in 2022.
Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. The diagnostics and research laboratories segment is dominating the market in 2022.
Based on country, the market is segmented into Brazil, Argentina, and the rest of South & Central America. Further, Brazil is dominating the market in 2022.
A few key players dominating the South & Central America genotyping market are BioTek Instruments, Inc.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Integrated DNA Technologies, Inc.; MERCK KGaA; QIAGEN; and Thermo Fisher Scientific Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Genotyping Market - By Product and Services
1.3.2 South & Central America Genotyping Market - By Technology
1.3.3 South & Central America Genotyping Market - By Application
1.3.4 South & Central America Genotyping Market - By End User
1.3.5 South & Central America Genotyping Market - By Country
2. South & Central America Genotyping Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Genotyping Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Experts Opinion
5. South & Central America Genotyping Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process
5.3 Market Opportunities
5.3.1 Wide Applications of Genotyping
5.4 Future Trends
5.4.1 Rising focus on Personalized Medicine
5.5 Impact analysis
6. Genotyping Market- South & Central America Analysis
6.1 South & Central America Genotyping Market Revenue Forecast and Analysis
7. South & Central America Genotyping Market- by Product and Services
7.1 Overview
7.2 South & Central America Genotyping Market, By Product and Services, 2022 & 2028 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Bioinformatics
7.5.1 Overview
7.5.2 Bioinformatics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Instruments
7.6.1 Overview
7.6.2 Instruments: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
8. South & Central America Genotyping Market- by Technology
8.1 Overview
8.2 South & Central America Genotyping Market Share by Technology - 2022 & 2028 (%)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.4 Capillary Electrophoresis (CE)
8.4.1 Overview
8.4.2 Capillary Electrophoresis: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.5 Sequencing
8.5.1 Overview
8.5.2 Sequencing: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.6 Microarrays
8.6.1 Overview
8.6.2 Microarrays: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.7.1 Overview
8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Genotyping Market-by Application
9.1 Overview
9.2 South & Central America Genotyping Market Share by Application - 2022 & 2028 (%)
9.3 Diagnostics and Personalized Medicine
9.3.1 Overview
9.3.2 Diagnostics and Personalized Medicine: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.4 Pharmacogenomics
9.4.1 Overview
9.4.2 Pharmacogenomics: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.5 Animal Genetics
9.5.1 Overview
9.5.2 Animal Genetics: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.6 Agricultural Biotechnology
9.6.1 Overview
9.6.2 Agricultural Biotechnology: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Genotyping Market- by End User
10.1 Overview
10.2 South & Central America Genotyping Market Share by End User- 2022 & 2028 (%)
10.3 Diagnostic and Research Laboratories
10.3.1 Overview
10.3.2 Diagnostic and Research Laboratories: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.4 Pharmaceutical and Biopharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biopharmaceutical Companies: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.5 Academic Institutes
10.5.1 Overview
10.5.2 Academic Institutes: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Genotyping Market- Country Analysis
11.1 South & Central America Genotyping Market Revenue and Forecasts to 2028
11.1.1 Overview
11.1.3 South & Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.1.3.1 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.1 Overview
11.1.3.1.2 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.3 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.1.4 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.1.5 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.1.6 Argentina: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.3.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.1 Overview
11.1.3.2.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.3 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.2.4 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.2.5 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.2.6 Brazil: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.1.3.3 Rest of South & Central America: Genotyping Market- Revenue and Forecast to 2028 (USD Mn)
11.1.3.3.1 Overview
11.1.3.3.2 Rest of South & Central America: Genotyping Market- Revenue and Forecast to 2028 (USD Mn)
11.1.3.3.3 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.3.4 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.1.3.3.5 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.3.6 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
12. South & Central America Genotyping Market Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MERCK KGaA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioTek Instruments, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Genotyping Market -Revenue and Forecast to 2028 (US$ Million)
Table 2. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 3. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 4. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 5. Argentina: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 6. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 7. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 8. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 9. Brazil: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 10. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 11. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 12. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 13. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 14. Organic Developments Done By Companies
Table 15. Inorganic Developments Done By Companies
Table 16. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America Genotyping Market Segmentation
Figure 2. South & Central America Genotyping Market - By Country
Figure 3. South & Central America Genotyping Market Overview
Figure 4. Reagents and Kits Held Largest Share by Product and Services of South & Central America Genotyping Market
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. South & Central America Genotyping Market Impact Analysis of Driver and Restraints
Figure 9. South & Central America Genotyping Market- Revenue Forecast and Analysis - 2022 - 2028
Figure 10. South & Central America Genotyping Market, by Product and Services, 2022 & 2028 (%)
Figure 11. Reagents and Kits: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Genotyping Services: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Bioinformatics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Instruments: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. South & Central America Genotyping Market Share by Technology - 2022 & 2028 (%)
Figure 16. Polymerase Chain Reaction: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Capillary Electrophoresis: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Sequencing: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Microarrays: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Others: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. South & Central America Genotyping Market Share by Application - 2022 & 2028 (%)
Figure 23. Diagnostics and Personalized Medicine: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Pharmacogenomics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Animal Genetics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Agricultural Biotechnology: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Others: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. South & Central America Genotyping Market Share by End User- 2022 & 2028 (%)
Figure 29. Diagnostic and Research Laboratories: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Pharmaceutical and Biopharmaceutical Companies: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Academic Institutes: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Others: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. South & Central America Genotyping Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 34. South & Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)
Figure 35. Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Rest of South and Central America: Genotyping Market- Revenue and Forecast to 2028 (USD Mn)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security